Current Recommendations for Laboratory Testing and Use of Bone Turnover Markers in Management of Osteoporosis
Open Access
- 1 March 2012
- journal article
- review article
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 32 (2) , 105-112
Abstract
Lee J, et al. Ann Lab Med. 2012 Mar;32(2):105-112. https://doi.org/10.3343/alm.2012.32.2.105Keywords
This publication has 58 references indexed in Scilit:
- Comparison of total and intact aminoterminal propeptide of type I procollagen assays in patients with breast cancer with or without bone metastasesAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2011
- Secular trends in the incidence of hip and other osteoporotic fracturesOsteoporosis International, 2011
- The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to KnowThe Journal of Clinical Endocrinology & Metabolism, 2011
- Determination of an Applicable FRAX Model in Korean WomenJournal of Korean Medical Science, 2010
- Biochemical Markers of Bone Turnover, Hip Bone Loss, and Fracture in Older Men: The MrOS StudyJournal of Bone and Mineral Research, 2009
- Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone ClubInternational Journal Of Clinical Practice, 2008
- FRAX™ and the assessment of fracture probability in men and women from the UKOsteoporosis International, 2008
- Early Changes in Biochemical Markers of Bone Turnover Predict the Long-Term Response to Alendronate Therapy in Representative Elderly Women: A Randomized Clinical TrialJournal of Bone and Mineral Research, 1998
- Hip fractures in the elderly: A world-wide projectionOsteoporosis International, 1992
- SYMPTOMATIC HYPOCALCAEMIA AFTER TREATMENT WITH HIGH-DOSE AMINOHYDROXYPROPYLIDENE DIPHOSPHONATEThe Lancet, 1987